trvi: the income statement

MyFinsight

Trevi Therapeutics, Inc. (TRVI)

For the quarter ending 2025-06-30, TRVI made $1,386K in revenue. -$12,301K in net income. Net profit margin of -887.52%.

Unit: Thousand (K) dollars (except for numbers of shares and EPS)

	2025-06-30
Income tax benefit	-21
Research and development	9,389
General and administrative	4,333
Total operating expenses	13,722
Loss from operations	-13,722
Other expense, net	-7
Interest income, net	1,407
Interest expense	-
Total other income, net	1,400
Loss before income taxes	-12,322
Net loss	-12,301

Earnings per share basic	-0.09
Earnings per share diluted	-0.09
Weighted average number of diluted shares outstanding	130,350,391
Weighted average number of shares outstanding basic	130,350,391

Unit: Thousand (K) dollars (except for numbers of shares and EPS)